The 2023 AAN Annual Meeting took place in Boston, MA, from April 22-27. AAN 2023 brought together neurology professionals from across the world to learn, share, collaborate, & advance the field.

VJNeurology heard from renowned presenters on the latest ground-breaking news in neurology. Discover our exclusive coverage below!

View all videos

AAN Congress 2023

Boston, MA, 22-27 April 2023

AAN Congress 2023

Boston, MA, 22-27 April 2023

 
The 2023 AAN Annual Meeting took place in Boston, MA, from April 22-27. AAN 2023 brought together neurology professionals from across the world to learn, share, collaborate, & advance the field.

VJNeurology heard from renowned presenters on the latest ground-breaking news in neurology. Discover our exclusive coverage below!

View all videos

What's new?

View all
4:12
Safety and efficacy of deoxycytidine and deoxythymidine in treatment of POLG-related disorders
Kenneth Myers • 26 Apr 2023
4:06
Leadership development in neurology
Bruce Ovbiagele • 24 May 2023
1:18
Strategies to overcome cultural factors and perceptions about MS care
Mitzi Joi Williams • 22 May 2023
4:03
Contributors to the increase in autoimmune encephalitis misdiagnosis
Alfonso Sebastian Lopez • 10 May 2023

Multiple Sclerosis And Related Disorders

View all
3:22
Efficacy subgroup analyses from the Phase III CHAMPION-NMOSD trial
Michael Levy • 26 Apr 2023
8:25
Update on the role of the microbiome in MS
Anne-Katrin Pröbstel • 26 Apr 2023
2:19
Understanding of the early disease processes in MS
Augusto Miravalle • 5 May 2023
5:20
Results of ocrelizumab in treatment-naïve patients with early relapsing MS
João José Cerqueira • 27 Apr 2023

Sleep Disorders

View all
5:04
Exploring the potential of deep learning in sleep studies for predictive insights
Emmanuel Mignot • 11 May 2023
5:45
The relationship between sleep and neurodegeneration
Alberto Ramos • 2 May 2023
4:56
CBT mobile apps to treat insomnia
Michelle Jonelis • 27 Apr 2023
3:25
RBD phenoconversion and predictors of progression
Eric Geil • 12 May 2023

Movement Disorders

View all
4:05
Phase III trial update of P2B001 for Parkinson’s disease
Cheryl Fitzer-Attas • 9 May 2023
5:58
Phase II study investigating ANX005 in Huntington’s disease
Rajeev Kumar • 26 Apr 2023
2:20
Phase II study of NE3107 in levodopa/carbidopa-treated patients with Parkinson’s disease
Joseph Michael Palumbo • 26 Apr 2023
3:31
ND0612 vs oral immediate-release levodopa/carbidopa in patients with PD and motor fluctuations
Alberto Espay • 27 Apr 2023

Headache

View all
4:07
Simultaneous comparison of 25 acute migraine medications: a big data analysis
Chia-Chun Chiang • 26 Apr 2023
3:07
Zavegepant nasal spray for the acute treatment of migraine with and without aura
Timothy Smith • 26 Apr 2023

Epilepsy

View all
4:47
Safety and efficacy of microburst VNS
Cornelia Drees • 25 May 2023
4:06
Developments in seizure monitoring and forecasting tools
Daniel Goldenholz • 28 Apr 2023
The content of VJNeurology is intended for healthcare professionals